BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 14588231)

  • 1. [Clinical significance of tumor content of epidermal growth factor receptor in breast cancer].
    Mulero M; Fernández Raigoso P; Vázquez J; Lamelas ML; Corte D; Allende MT; Rodríguez JC; Vizoso F
    Rev Esp Med Nucl; 2003 Nov; 22(6):386-94. PubMed ID: 14588231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of epidermal growth factor receptor (EGFR) in hormone-independent breast cancers].
    Ruibal A; Garrido-Pumar M; Arias JI
    Rev Esp Med Nucl; 2006; 25(1):15-9. PubMed ID: 16540006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and prognostic value of EGFR in invasive breast cancer.
    Quintela I; Corte MD; Allende MT; Vazquez J; Rodríguez JC; Bongera M; Lamelas M; Gonzalez LO; Vega A; García-Muñiz JL; Astudillo A; Vizoso F
    Oncol Rep; 2005 Dec; 14(6):1655-63. PubMed ID: 16273272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor receptors in human breast and endometrial carcinomas.
    Llorens MA; Bermejo MJ; Salcedo MC; Charro AL; Puente M
    J Steroid Biochem; 1989; 34(1-6):505-9. PubMed ID: 2626045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific oncological contribution of cathepsin D and pS2 in human breast cancer: their relationship with TNM status, estradiol receptors, epidermal growth factor receptor and neu amplification.
    Bolufer P; Torregrosa MD; Gomez L; Munarriz B; López JA; Asins E; Espinoza S; Vera F; Vazquez C; Guillem V
    Clin Chim Acta; 1996 Mar; 247(1-2):89-103. PubMed ID: 8920230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epidermal growth factor receptor as a prognostic marker: results of 370 patients and review of 3009 patients.
    Fox SB; Smith K; Hollyer J; Greenall M; Hastrich D; Harris AL
    Breast Cancer Res Treat; 1994 Jan; 29(1):41-9. PubMed ID: 8018963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor angiogenesis in node-negative breast carcinomas--relationship with epidermal growth factor receptor, estrogen receptor, and survival.
    Fox SB; Leek RD; Smith K; Hollyer J; Greenall M; Harris AL
    Breast Cancer Res Treat; 1994 Jan; 29(1):109-16. PubMed ID: 7517221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of epidermal growth factor receptor (EGFR) in breast cancer as related to clinical, prognostic and cytometric factors.
    Pirinen R; Lipponen P; Syrjänen K
    Anticancer Res; 1995; 15(6B):2835-40. PubMed ID: 8669874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptors in human breast cancer: a plea for standardisation of assay methodology.
    Koenders PG; Faverly D; Beex LV; Bruggink ED; Kienhuis CB; Benraad TJ
    Eur J Cancer; 1992; 28(2-3):693-7. PubMed ID: 1591096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor.
    Poller DN; Hutchings CE; Galea M; Bell JA; Nicholson RA; Elston CW; Blamey RW; Ellis IO
    Br J Cancer; 1992 Sep; 66(3):583-8. PubMed ID: 1355662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytosolic concentrations of cathepsin D in 88 infiltrating ductal breast carcinomas having negative estrogen and progesterone receptors. Correlation with other clinical and biological parameters].
    Ruibal A; Arias J; Lapeña G; García Díez S; Tejerina A
    Rev Esp Med Nucl; 2001 Jun; 20(4):332-3. PubMed ID: 11940423
    [No Abstract]   [Full Text] [Related]  

  • 12. Hormone receptor expression in invasive breast cancer among Korean women and comparison of 3 antiestrogen receptor antibodies: a multi-institutional retrospective study using tissue microarrays.
    Bae YK; Gong G; Kang J; Lee A; Cho EY; Lee JS; Suh KS; Lee DW
    Am J Surg Pathol; 2012 Dec; 36(12):1817-25. PubMed ID: 23154769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relations between epidermal growth factor receptor and oestrogen and progesterone receptors in breast cancers of premenopausal and postmenopausal patients in Kuwait.
    Nasralla MY; Paszko Z; Omar YT; Ali MA; al Jazzaf H; Padzik H; Temmim L
    Eur J Cancer; 1992; 29A(1):76-81. PubMed ID: 1445750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane progesterone receptor alpha as a potential prognostic biomarker for breast cancer survival: a retrospective study.
    Xie M; Zhu X; Liu Z; Shrubsole M; Varma V; Mayer IA; Dai Q; Chen Q; You S
    PLoS One; 2012; 7(4):e35198. PubMed ID: 22496908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGF-R and steroid receptors in breast cancer: a comparison with tumor grading, tumor size, lymph node involvement, and age.
    Zeillinger R; Kury F; Speiser P; Sliutz G; Czerwenka K; Kubista E
    Clin Biochem; 1993 Jun; 26(3):221-7. PubMed ID: 8392451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic utility of snail in metaplastic breast carcinoma.
    Nassar A; Sookhan N; Santisteban M; Bryant SC; Boughey JC; Giorgadze T; Degnim A
    Diagn Pathol; 2010 Nov; 5():76. PubMed ID: 21110878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinico-biological impact of pS2 positivity in estrogen receptor negative-infiltrating ductal carcinomas of the breast].
    Ruibal A; Arias J; del Río MC; San Román JM; Lapeña G; Pardo C; Tejerina A
    Rev Esp Med Nucl; 2000 Oct; 19(6):428-33. PubMed ID: 11060273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Infiltrating ductal carcinomas of the breast in women over 60 years of age. Association with higher cellular proliferation and lower PS2, cell surface and cytosolic hyaluronic acid concentrations].
    Ruibal A; Arias J; Del Río MC; Resino C; Tejerina A
    Rev Esp Med Nucl; 2001 Dec; 20(7):525-9. PubMed ID: 11709137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The variation and clinical significance of hormone receptors and Her-2 status from primary to metastatic lesions in breast cancer patients.
    Zhu YY; Si W; Ji TF; Guo XQ; Hu Y; Yang JL
    Tumour Biol; 2016 Jun; 37(6):7675-84. PubMed ID: 26687919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of p185(HER-2/neu) protein in breast cancer and its association with other prognostic factors.
    Valerón PF; Chirino R; Vega V; Falcón O; Rivero JF; Torres S; León L; Fernández L; Pestano J; Díaz-Chico B; Díaz-Chico JC
    Int J Cancer; 1997 Apr; 74(2):175-9. PubMed ID: 9133451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.